Skip to main content

Sandoz launches TYRUKO® (natalizumab-sztn) in US, as first and only multiple sclerosis biosimilar

Sandoz, the global leader in affordable medicines, today announced that TYRUKO® (natalizumab-sztn) is available to patients in the US. Developed by Polpharma Biologics, TYRUKO® is the first and only US Food and Drug Administration (FDA) approved natalizumab biosimilar for the treatment of relapsing forms of multiple sclerosis (MS).
Lupin’s Nagpur Unit-1 Clears U.S. FDA Pre-Approval Inspection with No Observations
Global pharmaceutical company Lupin Limited announced today that the United States Food and Drug Administration (U.S. FDA) has successfully completed a product-specific pre-approval inspection at its Unit-1 oral solid dosage facility in Nagpur.
GanLum delivered a 97.4% cure rate for Malaria in landmark phase III trial
Novartis has announced compelling Phase III results for GanLum (ganaplacide/lumefantrine, KLU156), a next-generation antimalarial developed with Medicines for Malaria Venture (MMV). The combination therapy achieved a 97.4% PCR-corrected cure rate in the KALUMA study marking a major advancement in malaria treatment amid rising drug resistance across Africa.
Merck to Acquire Cidara Therapeutics, Inc

Merck (NYSE: MRK), known as MSD outside of the United States and Canada, and Cidara Therapeutics, Inc, a biotechnology company developing drug-Fc conjugate (DFC) therapeutics, today announced that the companies have entered into a definitive agreement under which Merck, through a subsidiary, will acquire Cidara for 221.50 USD per share in cash, for a total transaction value of approximately 9.2 billion USD.

Openings for Drugs Inspector (419 posts) under Ministry of Health and Family Welfare, recruitment rules
Bachelors degree in Pharmacy or Pharmaceutical Sciences or Medicine with specialisation in Clinical Pharmacology or Microbiology from a recognised University or institute. 
Pharmacy Council of India looking for M.Pharm candidates in policy bureau
M.Pharm obtained from an Institution / authority approved under section 12 of the pharmacy Act,1948. A registered pharmacist
Hiring Pharmacy graduates under Directorate of Planning, Government | Salary Rs. 1 lakh month
A Degree or higher in Public Health or Health Administration or Demography or Community Medicine or Medicine or Nursing or Health Economics or Pharmacy or a related field.
Opportunity for PhD, M.Pharm, MSc as Research Associate at PGIMER | Salary Rs. 67,000 plus HRA
PhD / M.Pharma Pharmacy Practice / Postgraduate degree in Public Health/Statistics/ Epidemiology/ Health Sciences/ Environmental Sciences/ Life Sciences/Population Sciences/Demography/Health Economics/ HTA 
Career for B.Pharm / MBA at Government of India Enterprise HLL Lifecare | Annual CTC Rs.12.69 lakh
B.Pharm / MBA. Develop and implement procurement plans for pharmaceutical products, raw materials, packaging materials, and consumables. HLL Lifecare
District Health Society invites for post of Pharmacist | 8 posts
D.Pharm Intgrated Pharmacy Course AYUSH. certificate issued by State Govt
Opportunity for Pharmacists under Central Government Health Scheme | 04 posts
Degree or Diploma in Ayurvedic Pharmacy from any recognized institute. Age Limit Not exceeding 64 years, as on date of publication of advertisement.
Advertisement for M.Pharm or MSc as SRF at RARI | Salary Rs. 42,000 pm
Postgraduate degree in Chemistry or M.Pharm. with Pharmaceutical Chemistry from a recognized University Institution Two years of experience in the field of research and development.
University of Hyderabad looking for M.Pharm, MSc candidates - 5 posts
Bachelors Degree in Natural Sciences / Masters Degree in Natural Sciences / MPharm. Genetic polymorphism associated with HECT family ubiquitin ligase genes in breast cancer patients as potential biomarkers
Opportunity for Pharm.D or MSc under HTAInRegional Resource Centre, AIIMS
Graduate in Science OR Master in Science / relevant subjects from a recognized University from a recognized institution  OR PharmD, Doctor of Pharmacy from a recognized institution
THSTI invites applications from Indian citizens for the Ph.D. program at Osaka University, Japan
The Translational Health Science and Technology Institute invites applications from Indian citizens for the Ph.D. program at Osaka University, Japan, for admission in April 2027.
Openings in Production, QA, QC at Unicure Pharma - M.Pharm, B.Pharm, MSc Apply
B.Pharm / B.Sc (Chemistry) / M.Sc with HPLC expertise. Freshers with B.Pharm/B.Sc/M.Sc. Unicure Pharma
66 Pharma Openings through Common examination for AIIMS and Other Central Govt Institutes
B. Pharm. from a recognized university or Pharm. D M.Sc. Medical Microbiology / Medical Pharmacology / Medical Biochemistry / Medical Bacteriology / Medical Virology from a recognized university.
Career for Pharmacy, Life Sciences candidate at CDSA
Life Sciences with a minimum of two years of experience in clinical research, OR Professional degree in MBBS, BDS, BVSc, BAMS, BHMS, BUMS, BSMS, BNYS, B.Sc. Nursing, BPT, B.Pharm, with a minimum of one year of experience in clinical research
Advetisement for the Post of Deputy Manager at HLL Lifecare - B.Pharm, Pharm.D Apply | Annual CTC Rs. 12.21 Lakhs
BHM / B.Pharm / Pharm.D / MBA ; Minimum 3 years of managerial experience in leading a team of 3 - 5 members and overseeing day-to-day functional or business activities in hospital management, retail pharmacy operations, diagnostic services, healthcare project implementation.
IMTech Opportunity for M.Pharm, MSc to work in tuberculosis pathogenesis and drug tolerance project
Masters / Integrated Masters in Natural or Agricultural or Pharmaceutical Sciences/ MVSc/ Animal Sciences. OR Bachelors degree in Engineering or Technology or Medicine from a recognized University.
Subscribe to